LUNG COLLAPSE DURING MINITHORACOTOMY REDUCES …
Transcript of LUNG COLLAPSE DURING MINITHORACOTOMY REDUCES …
LUNG COLLAPSE DURING MINITHORACOTOMY REDUCES PENETRATION
OF CEFUROXIME TO THE TISSUE – INTERSTITIAL MICRODIALYSIS STUDY
IN ANIMAL MODEL
Martin Děrgel1,
1 Department of Cardiac Surgery, Charles University, Faculty of Medicine and University
Hospital Hradec Králové; 2 Department of Pharmacology, Charles University, Faculty of
Medicine in Hradec Králové; 3 Department of Anesthesiology, Resuscitation and Intensive
Medicine, Charles University, Faculty of Medicine and University Hospital Hradec Králové; 4 Institute of Clinical Biochemistry and Diagnoses, Charles University, Faculty of Medicine
and University Hospital Hradec Králové; 5 Animal Research Facility, Faculty of Military
Health Sciences, University of Defense, Hradec Králové
Co-authors: M. Voborník1, M. Pojar1, M. Karalko1, J. Gofus1, J. Chládek, 2*, Z. Turek3, J.
Maláková4, Š. Studená2, V. Radochová5, J.Manďák1
*Correspondingauthor: J.Chládek, Department of Pharmacology, Charles University,
Faculty of Medicine in Hradec Králové
Tutor: Prof. Jiří Manďák, M.D., Ph.D.
Background
One-lung ventilation facilitates surgical exposure during minimally invasive cardiac surgery.
However, deeper knowledge on antibiotic distribution within a collapsed lung is mandatory
for an effective antibiotic prophylaxis of pneumonia.
Methods
The pharmacokinetics/pharmacodynamics (PK/PD) of cefuroxime were compared between
the plasma and interstitial fluid (ISF)of collapsed and ventilated lungs in ten anesthetized
pigs, which were ventilated through a double-lumen endotracheal cannula. Cefuroxime (20
mg/kg)was administered in single 30-min i.v. infusion. Samples of blood and lung
microdialysatewere collecteduntil 6 hourspostdose.Ultrafiltration, in-vivoretrodialysis and
high-performance liquid chromatography-tandem mass spectrometry were used to determine
plasma and ISF concentrations of free drug. The concentrations were subjected to non-
compartmental analysis and compartmental modelling.
Results
The concentration of freecefuroxime in ISF was lower in the non-ventilated lung than the
ventilated one, evidenced by a lung penetration factor of 47% vs. 63% (P<0.05),the ratio
between maximum concentrations (65%, p<0.05) and the ratio between the areas under the
concentration-time curve (78%, p=0.12).The time needed to reach a minimum inhibitory
concentration (MIC) was 30-40% longer for a collapsed lung than for a ventilated one. In
addition, a delay of 10-40 minutes was observed for lung ISF when compared to plasma. The
mean residence time of cefuroxime was longer in the former than inthe latter. Regarding
sensitive strains (MIC≤4 mg/L), the percentage of the inter-dose interval with a concentration
above MIC (%fT>MIC) was comparable in all fluids.
Conclusion
The concentration of cefuroxime in the ISF of a collapsed lung is lower thanin a ventilated
one; further, its equilibration withplasma isdelayed. Prolonging the time window between
cefuroximedosage and surgery is recommended, as well as intensifying the dose prophylaxis
against pathogens with higher MICs. PK/PD models enablean optimal prophylactic regimen
combining initial and continuous infusions.
MINISTERNOTOMY FOR AORTIC VALVE REPLACEMENT: IS IT BETTER IN
TERMS OF PULMONARY FUNCTIONS AND QUALITY OF LIFE?
Gofus Ján1
1 Department of Cardiac Surgery, Charles University, University hospital and Faculty of
Medicine in Hradec Kralove, Hradec Kralove, Czech Republic; 2 Department of Pulmology,
Charles University, University Hospital and Faculty of Medicine in Hradec Kralove, Hradec
Kralove, Czech Republic
Co-Authors: M. Voborník1, A. Myjavec1, V. Koblížek2, J. Vojáček1, M. Pojar1
Tutor: Marek Pojar, M.D., Ph.D1
Introduction
Ministernotomy (i.e. upper hemisternotomy) is commonly used as a miniinvasive approach for
aortic valve replacement worldwide. It was shown to provide shorter artificial ventilation time,
shorter ICU stay and lower blood loss comparing with standard median sternotomy approach.
Apart from that, preservation of lower half of thoracic cage could lead to better pulmonary
functions and quality of life postoperatively. There is no recent prospective randomised study
proving this hypothesis.
Aims
To show that ministernotomy leads to better outcomes in pulmonary function and quality of
life testing in short-term postoperatively.
Methods
Between 05/2017 and 05/2019, 30 patients undergoing aortic valve replacement at our
department were prospectively randomised to ministernotomy and full sternotomy group in 1:1
ratio. Standard perioperative data were recorded together with pulmonary function testing
(PFT), 1 minute Sit-to-Stand test (1m-STST) and SF-36 Health Survey. PFT and 1m-STST
were performed one day before surgery, one week after and three months after the surgery. SF-
36 Health survey was filled out preoperatively and three months postoperatively.
Results
There was no difference in standard preoperative characteristics between the two groups.
Ministernotomy group had better preoperative values of obstructive pulmonary parameters
(p<0.001 for FEV1, p<0.001 for FEV1/FVC, p<0.01 for MEF50%). 2 patients (13.3%) from
miniinvasive group required conversion to standard approach. We found no difference in
operative and early postoperative outcomes, except significantly higher blood loss in
sternotomy group (p<0.01). Ministernotomy was shown to cause significantly greater
obstructive defect of pulmonary functions (p=0.02 for FEV1, p=0.03 for FEV1/FVC, p=0.03
for MEF50%). On the other hand, ministernotomy lead to greater improvement in quality of
life postoperatively in terms of physical functioning and general health. Outcomes of 1m-STST
were equal in both groups. No other significant difference was found.
Discussion
In accordance with other studies, our study showed that ministernotomy is non-inferior to
standard full sternotomy approach in terms of standard postoperative outcomes. It lead to lower
blood loss in early postoperative period. Shortening of arteficial ventilation time or ICU stay
was not proved in our conditions.
Stoliński et al. (2016) examined change of pulmonary functions after minithoracotomy
approach for aortic valve replacement and showed superiority of minimally invasive approach.
Results of our study (concentrating on ministernotomy) favor standard full sternotomy
approach. However, the outcomes are disputable because of different values of obstructive
parameters between the two groups preoperatively.
To our knowledge, 1m-STST was never used in cardiac surgery before. It shows tendence to
drop in first week postoperatively and to improve beyond preoperative values after three
months. However, the test was not suitable for comparison of the two surgical approaches.
Quality of life seems to be better in ministernotomy group postoperatively in accordance with
other papers.
Conclusion
Ministernotomy approach seems to be at least as safe as full sternotomy regarding standard
postoperative outcomes. Quality of life could be better than in full sternotomy group. It can lead
to more notable drop in PFT outcomes but clinical implication of this finding remains
questionable. 1m-STST is probably not suitable for comparison of surgical approaches in
cardiac surgery.
References
1. Kirmani BH, Jones SG, Malaisrie SC, Chung DA, Williams RJ. Limited versus full
sternotomy for aortic valve replacement. Cochrane Database Syst Rev
2017;4:CD011793.
2. Phan K, Xie A, Tsai Y-C, Black D, Di Eusanio M, Yan TD. Ministernotomy or
minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network
meta-analysis. Ann Cardiothorac Surg. 2014;4(1):3-14.
3. Stoliński J, Plicner D, Gawęda B, et al. Function of the Respiratory System in Elderly
Patients After Aortic Valve Replacement. J Cardiothorac Vasc Anesth.
2016;30(5):1244-53.
MUTATION IN THE PBP3 GENE AND THEIR EFFECTS ON RESISTANCE TO
BETA-LACTAM ANTIBIOTICS IN HAEMOPHILUS INFLUENZAE STRAINS
Vladislav Jakubů 1,2
1Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague 2Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
Co-authors: L. Mališová1, M. Musílek1, H. Žemličková1,2
Tutor: Assoc. Prof. Helena Žemličková, M.D., Ph.D.
Introduction, objectives
β-lactam antibiotics are the first choice drug in the treatment of Haemophilus influenzae
infections. Since 2010, the National Reference Laboratory for Antibiotics (NRL for ATB) has
been registering an upward trend in the incidence of H. influenzae strains with a non-enzymatic
type of resistance to these antibiotics. Non-enzymatic resistance is due to a decrease in β-
lactams binding to the cell wall due to a mutation of the penicillin-binding protein 3 (PBP3)
encoded by the ftsI gene. This type of resistance is difficult to detect by phenotypic methods.
The aim of this study was to determine the occurrence of mutations, their effect on resistance
to β-lactam antibiotics and identify the epidemiological relationship between strains.
Methods
During 2014-2018, 229 H. influenzae strains were sent to NRL for ATB from 39 clinical
laboratories to confirm non-enzymatic resistance to β-lactams. Detection of ftsI gene mutations
was performed by sequencing a fragment of the ftsI gene (621bp). The obtained nucleotide
sequence was converted into an amino acid sequence and compared to the amino acid sequence
of a reference non-mutated strain (sw Bionumerics). Multilocus sequence typing (MLST) was
used for epidemiological typing followed by the Single locus variant analysis of clonal
complexes (sw Goeburst). The sensitivity of detection of non-enzymatic resistance by
individual β-lactam antibiotics was determined by the disc diffusion method (EUCAST
methodology).
Results
Comparative analysis revealed 23 different amino acid (AA) substitutions in PBP3: V329I,
D350N, S357N, A368T, M377I, S385T, A388V, L389F, P393L, A437S, I449V, I491V,
G490E, R501L, A502S, A502T5, A502T5, A502T5 I519L, N526K, A530, T532S. 37
combinations of these AA substitutions were found (Figure 1). The most common combination
was “D350N, M377I, A502V, N526K”, which was carried by 35% of strains from the tested
group. When substitutions occur in combinations, a “basic” substitution N526K or R517H is
always present. In no combination are N526K and R517H substitutions together. Strains
resistant to the 3rd generation cephalosporins always contained at least the S385T and L389F
substitutions. The rest of the strains analyzed showed a wide variety of mutations. The strains
were epidemiologically diverse, 81 MLST types found (Figure 2).
Figure 1.
Figure 2. Clonal complex analysis
Discussion
The contribution of individual mutations to resistance levels is difficult to determine, only two
(S385T and L389F) have a clear causal relationship to resistance (resistance to the 3rd
generation cephalosporins). Clonal experiments to confirm the contribution of individual AA
substitutions to resistance have not been performed and may possibly be subject to further
study. There is no single clone spread in the Czech Republic, as it results from the analysis of
clonal complexes (Figure 2).
Conclusions
Isolates with non-enzymatic resistance due to mutation of the ftsI gene can be reliably detected
in routine practice only by simultaneous examination of penicillin, ampicillin, amoxicillin /
clavulanate and cefuroxime by the disk diffusion method. A third of strains carried combination
“D350N, M377I, A502V, N526K”, but these strains are not epidemiologically homogenous,
belong to 14 ST.
Blue ellipses – clonal complexes (CC)
with more than 10 strains: CC1218 – 23
strains, CC103 – 18 strains, CC396 – 11
strains.
Red ellipse – the most extensive,
CC1034 – 64 strains.
"Supported by MH CZ - DRO (" National Institute of Public Health - NIPH, 75010330 ")
References
1. Pracovní skupina pro monitorování rezistence (PSMR). Respirační studie ATB
rezistence. Dostupné http://www.szu.cz/respiracni-studie-atb-rezistence
2. Ubukata K, Shibasaki Y, Yamamoto K, el al. Association of amino acid substitutions in
penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative
ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45;
6: 1693–1699.
3. Witherden EA, Kunde D, Tristram G. PCR screening for the N526K substitution in
isolates of Haemophilus influenzae and Haemophilus haemolyticus. J Antimicrob
Chemother 2013; 68: 2255-2258.
4. Identification of PBP3 mutations in invasive isolates. Dostupné na
https://pubmlst.org/hinfluenzae/.
5. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables
for interpretation of MICs and zone diameters, version 7.1, 2017 Dostupné na
http://www.eucast.org/clinical_breakpoints/Clinical breakpoints - bacteria (v 9.0).
NANO-FORMULATED CURCUMIN IN THE TREATMENT OF THE SPINAL
CORD INJURY
Petr Krůpa
Department of Neurosurgery, Faculty of Medicine in Hradec Králové, Charles University in
Prague, Institute of Experimental Medicine v.v.i., The Czech Academy of Sciences
Co-authors: B. Svobodova, J. Dubisova, S. Kubinova, P. Jendelova, L. Machova Urdzikova
Tutor: Prof. Svatupluk Řehák, M.D., Ph.D.
Co-tutor: Assoc. Prof., Dr. Pavla Jendelová, Ph.D.
Introduction
Severe traumatic spinal cord injury (SCI) even in the 21st century remains a challenging medical
condition. Current therapies in the best medical praxis are limited to spinal cord decompression,
high dose corticosteroids, and rehabilitation, all of which result in modest and often very limited
recovery. A permanent or long-lasting neurological deficit is the result of the cascade of
pathophysiological processes, which involve primary and secondary injury. Secondary injury
promotes a series of cellular and molecular events, developing an inflammatory response and
cytokine production, followed by the formation of oedema and free radicals and finally resulting
in ischemia, apoptosis and necrosis of neural and glial cells
Curcumin (1,7-bis[4-hydroxy-3-methoxyphenyl]-1,6-heptadiene-3,5-dione) is a polyphenolic
component derived from the Indian spice - curcuma longa. Curcumin has a wide range of
pharmacological activities, including amongst others anti-inflammatory, antioxidant,
antiinfectious and specially neuroprotective properties (1). Curcumin reduces the production of
reactive oxygen species (ROS), lipid peroxidation and subside the inflammatory responses by
inhibiting the NF-κB pathway. More importantly, the above-mentioned result in a functional
improvement after SCI (2). However, clinical use of the curcumin remains challenging because
of his poor bioavailability. Recently, complexation of the curcumin with various molecules
have been successfully attempted with improved systemic distribution. In our study we used
high purity Curcumin contained within LipodisqTM - biodegradable lipid-based discoidal nano-
particle (Nanocurcumin).
Aims
The main purpose of this study was to investigate the neuroprotective potential of the novel
synthetized drug nanocurcumin on the functional recovery, tissue repair and levels of
inflammatory interleukins after SCI. We chose repetitive, daily, systemic subcutaneous delivery
in combination with local delivery to the site of the lesion, weekly for the first four weeks after
SCI. The effect was assessed by series of behavioural, histological, immunohistochemical and
qPCR analysis.
Methods
Experiment was performed on 10-weeks-old male Wistar rats with the body weight varying
270-300 g. SCI was introduced with the Balloon-induced ischemic-compression model of SCI.
After the surgery, rats were randomly divided into two groups - Nanocurcumin treated group
(n=21) and Nanocarrier (control) treated group (n=11). Nanocurcumin was applied both
directly in situ and systemic (subcutaneously). A direct application of Nanocurcumin around
the dura mater was performed immediately after SCI and then by minimal invasive approach
weekly 7., 14. and 28. day after SCI followed by daily application into the subcutaneous tissue
of the rats back.
Through the experiment the behavioural assessment was regularly performed (BBB, beam walk
test, motoRater). After 9 weeks of behavioural testing, all the animals were perfused with 4 %
paraformaldehyde in PBS and their spinal cords were removed, embedded in paraffin and cut
into cross sections. Histological and immunohistochemical analysis of the tissue sparing, glial
scar and axonal sprouting was performed. To assess the inflammatory dynamic response, qPCR
of selected genes and cytokines was performed 1st and 14th day and 9th week after SCI.
Results
1. Behavioural testing: In the basic locomotor tests (BBB, beam walk) we observed a
trend towards the improved locomotor skills of injured rats in the nanocurcumin treated
group. Significantly improved motor biomechanics of the paw and better self-carrying
ability was observed in the advance biomechanical testing using the motoRater.
2. Histological assessment: In the nanocurcumin treated group was achieved significantly
greater sparing of the white matter tissue cranially to the centre of the lesion.
Nanocurcumin also reduced the total GFAP+ area representing the glial scar as well as
the number of the protoplasmatic astrocytes in the centre of the lesion. Axonal sprouting
of GAP43+ fibers was insignificantly increased in the nanocurcumin treated groups.
3. qPCR: Significant changes in the dynamics of the inflammatory cytokines were found.
1 day after the treatment there was a significantly lower expression of IL-11 whereas 14
days after the treatment, there was significant up-regulation in the expression of
RANTES (CCL5), IL-11 and IL-12 and.
Conclusions/Summary
In conclusion, our study proved the feasibility of the new delivery system of curcumin with a
beneficial role on recovery after SCI. We found significant changes in the locomotor patterns
of the hind-limbs. Histology and immunohistochemistry proved significant beneficial role in
protection of the white matter and reduction of the glial scar. We also observed
immunomodulatory properties with ameliorating of the local immune response in the early
stage of SCI.
References
1. Ormond DR, Peng H, Zeman R, Das K, Murali R, Jhanwar-Uniyal M. Recovery from
spinal cord injury using naturally occurring antiinflammatory compound curcumin:
laboratory investigation. Journal of neurosurgery Spine. 2012;16(5):497-503.
2. Machova Urdzikova L, Karova K, Ruzicka J, Kloudova A, Shannon C, Dubisova J, et
al. The Anti-Inflammatory Compound Curcumin Enhances Locomotor and Sensory
Recovery after Spinal Cord Injury in Rats by Immunomodulation. International journal
of molecular sciences. 2015;17(1).
A PORCINE MODEL OF SKIN WOUND INFECTED WITH
A POLYBACTERIAL BIOFILM
Jan Kucerab,d,e
aBiomedical Center, Faculty of Medicine in Pilsen, Charles University; bContipro , a.s., Dolni
Dobrouc; cFaculty of Medicine, Slovak Medical University, Bratislava, SK; dInstitute
of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University; eCzech Centre for Phenogenomics, Institute of Molecular Genetics/BIOCEV, Vestec;
fDepartment of Dermatology, Third Faculty of Medicine, Charles University, Prague; gInstitute
of Molecular and Translational Medicine, Palacky University, Olomouc; hUniversity
of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Pardubice; iInstitute of Animal Science, Dept. of Pig Breeding, Kostelec nad Orlici
Co-authors: P. Kleina,b*, M. Sojkab,c, J. Matonohovab , V. Pavlikb,f, J. Nemecb, G. Kubickovab,
R. Slavkovskyb,g, K. Szuszkiewicz b,h, P. Daneki, M. Rozkoti, V. Velebnyb.
Tutor: Prof. Jaroslav Mokry, M.D., Ph.D.
Introduction
It is estimated that 1–2% of people in developed countries experience a chronic wound that will
not heal within four weeks of standard wound care during their life. Although the impaired healing
of such wounds is multifactorial, presence of bacterial biofilms is a proved and important factor.
The eradication of mature biofilm from the wound bed is problematic as bacteria in this form are
highly tolerant to same doses of antibiotics that are effective against planktonic bacteria. Therefore,
there is a growing need to develop and test specially designed treatments for chronically infected
wounds. There is a lack of appropriate in vivo models for studying the healing of chronic infected
wounds, which would closer resemble human-type of wound healing. The skin of pigs is similar
with human skin anatomically, physiologically and biochemically and like human skin, it heals
predominantly by re-epithelization which makes the pig a very valuable in vivo wound healing
model.
Methods
The model was established in 10 castrated male minipigs (Minnesota – type breed) of 13 months
of age. Five wounds reaching the subcutaneous fat (25 × 25 × 5 mm) were excised on each flank.
Four animals served as uninfected saline-treated controls and wounds of six individuals were
infected with an in vitro pre-cultured modified Lubbock type chronic wound multi-species biofilm
consisting of Staphylococcus aureus, Enterococcus faecalis, Bacillus subtilis and Pseudomonas
aeruginosa isolated from chronically infected wounds of clinical patients, and assessed for biofilm
production ability and presence of several virulence factors such as leukocidins and haemolysins
production, and gelatinase and hyaluronidase activity. All wounds were re-bandaged and
documented twice a week. On days 3, 7, 10, 14, and 24 post induction/infection one of five wounds
on each flank was sampled for quantitative microbiology cultivation, histology examination and
gene expression analyses.
Results
The presence of a biofilm significantly affected wound closure defined as the percentage of healed
area compared to the initial wound area measured on day 0. The largest differences (control /
inoculated) were observed on days 7, 10, and 14 (45 %/ 21 %, 66 %/ 37 %, and 90 % / 57 %).
Bacterial counts of the four species used for wound infection behaved differently. E. faecalis slowly
decreased during the course of the experiment. P. aeruginosa was the most abundant bacterial
species in the first 10 days p.i., while a consecutive decrease in the species load was observed from
day 3 until day 24 p.i. In contrast, S. aureus counts appeared to be relatively stable in the first 14
days p.i. and B. subtilis was not detected in the wounds after two weeks. Histological evaluation of
infected wounds revealed necrotic changes, significant increase and extension of both acute and
chronic inflammatory reaction and notably delayed onset (day 10) of decreased quality granulation
tissue formation. Histochemical staining and immunohistochemical detection of individual
bacterial strains confirmed presence of bacteria in a form of biofilm with corresponding production
of specific extracellular polymeric substances. Despite the delay of proliferative phase onset in
infected animals, the wounds were almost or completely epithelised by day 24 in both groups. Gene
expression analysis detected significant elevation of inflammatory mediators interleukin 8, C-X-C
motif chemokine 13 and arginase 1 on days 7, 10 and 14, accompanied by increase of oxidative
stress modulating genes expression such as superoxide dismutase 2 and angiopoetin-like 4.
Enhanced expression of matrix metalloproteinases 1 and 3 and decreased production of collagen 1
and laminin 2 were also found in infected wounds. Factors evaluated suggest prolonged
inflammation, enhanced oxidative stress and perturbed granulation tissue formation.
Discussion
The pig has been selected as a more clinically relevant wound healing model animal due to similar
wound healing mechanisms. Limitations of this model are 1) an availability of only young and
healthy animals without systemic illness typical for patients with chronic wounds, and 2) wound
localisation on animal non-exudating flanks versus usually exudating defects of lower limbs in
human patients. In order to increase the likelihood of successful experimental wound infection, the
bacteria were selected on bases of certain virulence factors presence. The presence of biofilm
caused severe infection and overall impairment of wound healing. The biofilm persisted at least for
two weeks and the rate of wound closure was significantly affected between days 7 and 17. Both
histology evaluation and gene expression profiles corresponded to increased inflammatory and
proteolytic condition and perturbed granulation, resembling the state in clinical chronic wounds.
Conclusion
We were able to successful set up a porcine excisional skin wound model infected with multi-
species biofilm. This model is suitable for studying of host-pathogen interactions occurring during
wound healing events. Within the one-week window this model could be useful also for monitoring
of impact of potential novel antimicrobial/anti-biofilm agents intended for wound biofilm
elimination and wound healing effects.
CYTOLOGICAL-ENERGY ANALYSIS OF PLEURAL EFFUSIONS FROM PATIENTS
WITH CHEST EMPYEMA AND OTHER IMPAIRMENT WITH PREDOMINANCE OF
NEUTROPHILS IN PLEURAL EFFUSION
Inka Matuchová1,2
1Department of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Králové, Charles
University; 2Biomedical Centre, Masaryk Hospital Ústí nad Labem; 3Department of Thoracic Surgery,
Masaryk Hospital Ústí nad Labem
Co-authors: J. Kubalík1,3, E. Hanuljaková2. I. Staněk3, P. Kelbich1,2
Tutor: prof. RNDr. Jan Krejsek, CSc.1
This work was supported by Charles University, Faculty of Medicine in Hradec Králové, Czech
Republic, project ‘PROGRES Q40/10’ and by the Internal Grant of the Krajská zdravotní, a.s. in Ústí
nad Labem, Czech Republic ‘IGA-KZ-2017–1-5’.
Introduction
Pleural infections by extracellular bacteria can be very serious. It affects approximately 100,000
patients in the Czech Republic every year. Some causes develop to the empyema with high mortality
[1,2]. Its essence is a purulent inflammation with oxidative burst on neutrophils. This type of
inflammatory response consumes a lot of oxygen and leads to the fast development of anaerobic
metabolism in the pleural cavity. We assess this process using frequency of neutrophils and coefficient
of energy balance (KEB) values in pleural effusions. The KEB values present a theoretical average
number of adenosine triphosphate (ATP) produced from one molecule of glucose under set conditions
in the pleural cavity. Concentrations of lactate dehydrogenase (LD) and aspartate aminotransferase
(AST) catalytic activities in pleural effusions are useful parameters for evaluation of tissue damage in
the same locality [3, 4, 5].
Aim
Our aim was to compare intensity of local immune response and seriousness of tissue damage in
pleural cavity of patients with chest empyema and patients with transudative pleural effusions, with
pneumonia and after chest surgery. We used a cytological-energy analysis and assessment of LD and
AST catalytic activities in pleural effusions.
Methods
We investigated in total 634 samples of the pleural effusions taken from 283 patients with chest
empyema, 58 patients with heart failure and systemic sepsis (transudative effusions), 89 patients after
chest surgery without inflammation, 108 patients after chest surgery with inflammation and 96 patients
with bacterial pneumonia. Evaluated parameters were relative frequencies of neutrophils, KEB values
and concentrations of LD and AST catalytic activities in pleural effusions. We assessed cut-off values
in pleural effusions for LD = 500.0 IU/L and for AST = 40.0 IU/L. Statistical analysis was performed
using the Mann-Whitney U test (p < 0.01 was considered as significant) via STATISTICA 13.3
software (StatSoft Inc., USA).
Results
Significant differences between patients with chest empyema and patients of other subgroups are
presented in the table.
Table: Cytological-energy analysis and LD and AST catalytic activities in pleural effusions
Groups of patients
N.gr. (%)# KEB LD (IU/L) AST (IU/L)
Median
(1th - 3thquartile)
Median
(1th - 3thquartile)
Median
(1th - 3thquartile)
Median
(1th - 3thquartile)
Transudative effusions
n = 58
58.0*
(49.5 – 73.5)
32.7*
(30.5 – 34.2)
150.6*
(110.1 – 290.7)
15.6*
(9.6 – 27.6)
Chest surgery without
inflammation; n = 89
77.0*
(60.0 – 87.0)
26.7*
(23.7 – 29.6)
685.2*
(410.4 – 1,212.0)
113.4*
(54.0 – 193.8)
Chest surgery with
inflammation; n = 108
87.0
(80.0- 92.0)
4.8*
(-38.2 – 14.1)
1,776.0*
(1,096.8 – 2,889.0)
222.9
(110.9 – 569.9)
Pneumonia
n= 96
84.5*
(75.0 – 91.3)
-169.6*
(-1,771.1 to -5.1)
1,430.4*
(869.2 – 3,212.1)
69.9*
(46.0 – 142.6)
Chest empyema
n = 283
88.0
(78.0 – 94.0)
-2,334.4
(-5,701.8 to -50.8)
4,170.9
(1,495.8 – 13,980.0)
236.4
(76.8 – 570.0)
# N.gr – relative frequencies of neutrophils (%); *significant difference p < 0,01
Discussion
Predominance of neutrophils in pleural effusions is typical for all presented subgroups of patients. The
type and intensity of local immunity response in the pleural cavity correlate with activation of these
immunocompetent cells. Reliable parameter for their specification is the KEB [4, 5]. Its lowest values
in patients with chest empyema, bacterial pneumonia and partly after chest surgery are typical for
purulent inflammation. The most intensive purulent inflammation in patients with chest empyema
correlates with the highest LD and AST catalytic activities in the pleural effusions. Their lower values
were found in the cases of lower intensity of purulent inflammation in patients with bacterial
pneumonia. The high KEB values in patients with transudative effusions and in the 2nd part of patients
after chest surgery excluded the purulent type of inflammation in the pleural cavity. Concentrations of
LD and AST catalytic activities under cut-off values in patients with transudative effusions show
absence of structural tissue damage in their pleural cavity. The lowest intensity or absence of purulent
inflammation and high LD and AST catalytic activities in pleural effusions from patients after chest
surgery shows surgical intervention as very important cause of tissue damage in the pleural cavity.
Conclusion
The KEB values in pleural effusions are useful parameter for determination of the type and intensity of
local immunity response in the pleural cavity. Concentrations of LD and AST catalytic activities in
pleural effusion are suitable parameters for evaluation of structural tissue damage in the same locality.
We found the most intensity of purulent inflammation simultaneously with the most serious tissue
damage in the pleural cavity of patients with chest empyema. We observed the milder intensity of
purulent inflammation and milder tissue injury in the pleural cavity of patients with bacterial
pneumonia. Absence of local inflammation and absence of structural tissue damage in the pleural
cavity were found in patients with transudative pleural effusions. Main reason of tissue injury in the
pleural cavity of patients after chest surgery is a surgical intervention.
References
1. Kašák, V. (2004): Diagnostika a léčba komunitní pneumonie v ambulantní praxi. Interní
Med., 6, 1, 31-33. 2. Garvia V., Paul M. (2019): Empyema. Treasure Island (FL): StatPearls Publishing, available at:
https://www.ncbi.nlm.nih.gov/books/NBK459237.
3. Krejsek J. (2016): Imunologie člověka. Hradec Králové, Garamon s.r.o, 495 stran.
4. Kelbich P, Hejčl A, Selke Krulichová I., et al. (2014): Coefficient of energy balance, a new parameter
for basic investigation of the cerebrospinal fluid. Clin Chem Lab Med, 52, 7, 1009-17.
5. Kelbich P., Malý V., Matuchová I. et al. (2019): Cytological-energy analysis of pleural
effusions. Ann Clin Biochem, 16, doi: 10.1177/0004563219845415.
CRYOPRESERVATION OF DENTAL PULP STEM CELLS
Nela Pilbauerová
Department of Dentistry, Faculty of Medicine and University Hospital in Hradec Králove
Tutor: Jakub Suchánek, M.D., Ph.D.
Introduction
Dental pulp stem cells (DPSCs) have opened a promising future in regenerative medicine,
because they are easily accessible from a dental pulp. As other stem cells, they have
remarkable features known as self-renewal, high proliferation activity and multilineage
differentiation. One of the principal goals in cell based therapies is to deliver individual
treatment to repair or regenerate tissue that has been lost due to an accident or disease. To
achieve this, isolated stem cells have to be amplified and stored in sub-zero temperatures and
thus preserved for future clinical applications.
Cryopreservation is a process of sustaining the viability of cells and tissues by freezing and
storing them at sub-zero temperatures, when biochemical reactions do not occur [1].
However, DPSCs could be a subject to an irreversible damage during the freezing or thawing
process, known as a freezing injury [2]. The exact mechanism is poorly understood, but in
general, irreversible changes to the DPSCs are explained by extracellular and intracellular
formation of ice crystals. To avoid that, there is a cryoprotective agent (CPA) incorporated
into the freezing medium to protect DPSCs during both the freezing and thawing process.
The most frequent freezing medium contains dimethyl sulfoxide (DMSO) as the CPA.
However, there are some documented concerns about its cytotoxicity and associated side
effects [3].
Aim
The purpose of this study was to cryopreserve DPSCs for 6 and 12 months using
uncontrolled-rate freezing technique and observe its effect on biological properties of the
stored stem cells.
Materials and methods
For this study we successfully isolated seven dental pulp stem cell lineages using an
enzymatic digestion method. The isolated populations of DPSCs were cultivated in a
modified cultivation medium (Alpha-MEM), for mesenchymal adult progenitor cells,
containing 2 % fetal bovine serum (FBS) and supplemented with growth factors and Insulin-
Transferrin-Selenium supplement (ITS). The cell viability in the 2nd and 8th passage, cell
count and cell diameter in every passage were examined using a Vi-Cell analyzer and Z2-
Counter. The phenotype analysis in the 3rd and 7th passages was performed using a flow
cytometer Cell Lab Quanta. For differentiation in chondroblasts and osteoblasts we used
commercially available differentiation media.
To assess the effect of uncontrolled-rate cryopreservation, we cryopreserved 1.5 x 106 cells
from the 1st passage for 6 and 12 months . We stored them in -82 °C using uncontrolled-rate
freezing technique and 10 % DMSO as the CPA. After their thawing in 37 °C thermal bath,
we repeated the same cultivation protocol as for the controlled unfrozen group.
Results
Unfrozen DPSCs kept the vitality over 90 % for the entire cultivation. We observed spindle-
like shaped cells. We cultivated them over 46.3 ± 3.2 cumulative population doublings (PD)
in average. The average population time (PT) was 48.9 hours ± 17.0 hours. They showed
high positivity for mesenchymal stem cell markers CD29, CD44, CD90, and negative
expression or low positivity for hematopoietic markers CD34, CD45. We were able to induce
chondrogenesis and osteogenesis.
In compassion to controlled group, DPSCs cryopreserved for 6 months had lower viability
after thawing, but they reached over 90 % viability at the end of the cultivation. The
phenotype analysis showed the phenotype for mesenchymal stem cells and they kept the
ability to differentiate into chondroblast-like and osteoblast-like cells. We cultivated them
over 42.8 ± 4.3 PD in average. The PT was 50.1 hours ± 11.3 hours.
On the other hand, we observed different trend in viability of DPCSs cryopreserved for 12
months. After thawing, we observed high viability over 90 %. However, it dropped to 88 % at
the end of the cultivation. Also, we did not observe any changes in the morphology or
phenotype or ability to differentiate in mature cells. The PD was 41.2 ± 4.1 and PT was 62.2
hours ± 18.0 hours.
Conclusion
The uncontrolled-rate freezing technique is not technically demanding and it is effective for
DPCSs cryopreservation. Cryopreserved cells kept the same morphology, phenotype of
mesenchymal stem cells and the ability to differentiate into mature cells as the controlled
group. They also remained proliferatively active after thawing process. However, we
observed a negative effect on viability with increasing period of time, which DPCSs were
cryopreserved for.
References
[1] Mullen F, Critser JK. The science of cryobiology. Cancer Treat Res 2007; 138:83–109
[2] Zhurova M, Woods EJ, Acker JP. Intracellular ice formation in confluent monolayers of
human dental stem cells and membrane damage. Cryobiology 2001; 61:133–41
[3] Zambelli A, Poggi D, Da Prada G et al. Clinical toxicity of cryopreserved circulating
progenitor cells infusion. Anticancer Res 1998; 18(6B): 4705–8
A NEW APPROACH FOR NEXT-GENERATION SEQUENCING OF BCR-ABL1
KINASE DOMAIN IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Michaela Řehounková
Institute of Clinical Biochemistry and Diagnostics, Charles University, Faculty of Medicine in
Hradec Králové and University Hospital Hradec Králové
Co-authors: K. Hrochová, L. Petrová, F. Vrbacký, P. Bělohlávková, P. Žák
Tutor: prof. MUDr. Vladimír Palička, CSc., dr. h. c.
Introduction
Every year, more than 60 patients in Czech Republic [1] are newly diagnosed with chronic
myeloid leukemia (CML). Typical for all CML cases is the occurrence of t(9:22) translocation
known as the Philadelphia chromosome, that can also occur in some cases of acute lymphatic
leukemia. This translocation is responsible for forming a fusion BCR-ABL1 gene. ABL1 gene
normally codes ABL1 protein with a character of tyrosine kinase, that is tightly regulated.
Pathological fusion BCR-ABL1 protein loses its autoinhibitive function and become
unregulated, which is the main driver of a malignant transformation. Nowadays this excessive
kinase activity can be successfully inhibited by tyrosine kinase inbihitors (TKIs) such as
imatinib as first-line therapy, or dasatinib, nilotinib, bosutinib and ponatinib as a TKIs of second
and third generation. But even after 15 years of safe and effective therapy, some patients don’t
reach the expected response. Insensivity to the therapy can be caused by mutations in ABL1
kinase domain, due to the conformational changes in mutated protein. Mutational analysis of
BCR-ABL1 kinase domain can be an important step in the decision of choosing the right TKI
when current response to the therapy is not optimal. [2-4]
Aims
Aim of this study is to develop a new method for detection of mutations in BCR-ABL1 kinase
domain that will be more sensitive and accurate than currently used method based on a Sanger’s
sequencing of ABL kinase domain.
Methods
Because of the required higher sensitivity and accuracy, we have chosen sequencing of the
BCR-ABL1 kinase domain with the Illumina platform for next generation sequencing (NGS)
and we prepared the entire library to be compatible with this system. As a primers for capturing
the fusion transcript we chose one primer in BCR gene and second in ABL1 gene [5], to prevent
amplification of normal ABL1 transcripts. Then we chose over 800bp-long area in ABL1 part
of gene, where all important mutations occur, and we designed 3 pairs of primers to cover this
area, in order to make a 3 overlapping amplicons with a maximal length of 450bp. These
amplicons were sequenced by an Illumina sequencer, but we also performed sequencing by
classical Sanger’s method, to compare the results.
We already analyzed 44 samples from 23 patients. Each sample was sequenced by NGS at least
2 times in a separate analyzing runs, to ensure sufficient accuracy of the results. Samples for
validation of the method were chosen as a screening from a clinical samples tested for a quantity
of BCR-ABL1 transcripts in years 2017-2019 in FNHK. Required relative quantification level
of BCR-ABL1 transcript was from 0,1% to 10% of the International scale (IS). Patients were
chosen because of long-term non-optimal response to the therapy, suddenly relapsed patients
with suspected mutations in ABL1 domain or patients with unstable levels of BCR-ABL1
transcript.
Results
Reads obtained from Illumina sequencer were analyzed through the NextGene software and
compared with reference sequence. Threshold level for confirming the presence of the mutation
was determined as 3%. From a screening cohort of samples were 23 samples analysed with a
mutation or insertion. From that was 12 samples from 5 patients harboring a clinically
significant mutation. Two samples were selected from a given group of patients, from which
we developed a control to ensure the correctness of analysis between individual runes. The first
sample included 2 mutations with high and low mutation levels, and the second sample was
without mutation. These controls were used in each run.
Conclusion
From the obtained data we showed a higher sensitivity of the method compared to classical
Sanger sequencing, which is a great advantage especially in the early stages of disease
development or relapse. Although the methodology is more demanding financially and
manually, it provides more reliable and accurate data. But the question remains, that need to be
further investigated, at what level can the mutation be considered significant for clinical
outcome. We would like to continue in screening in patients for mutations from retrospective
samples, but we also want to perform mutational analysis of BCR-ABL1 kinase domain that is
requested from hematologists in clinical samples from patients in actual need.
This study was supported by MH CZ - DRO (UHHK, 00179906).
Resources
1. Folber F., Koriťáková E. Portál české leukemické skupiny [online]. 2016 [cit. 2018-10-
01]. Available from: http://www.leukemia-cell.org.
2. Soverini, S., et al., In chronic myeloid leukemia patients on second-line tyrosine kinase
inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow
sensitive detection of emerging drug-resistant mutants. BMC Cancer, 2016. 16: p. 572.
3. Soverini, S., et al., Best Practices in Chronic Myeloid Leukemia Monitoring and
Management. Oncologist, 2016. 21(5): p. 626-33.
4. Branford, S., Molecular monitoring in chronic myeloid leukemia-how low can you go?
Hematology Am Soc Hematol Educ Program, 2016. 2016(1): p. 156-163.
5. Strhakova, L., et al., Use of direct sequencing for detection of mutations in the BCR-
ABL kinase domain in Slovak patients with chronic myeloid leukemia. Neoplasma, 2011.
58(6): p. 548-53.
IMPROVEMENT IN THE QUALITY OF LIFE IN PATIENTS WITH STABLE
MACULOPATHY BY IMPLANTING INTRAOCULAR MACULAR LENS AND
MODULATING VISUAL PLASTICITY BY TRANSCRANIAL ELECTRICAL
STIMULATION
Marketa Stredova
Ophthalmology Clinic Faculty University Hospital Hradec Kralove; Constitution Pat.
Physiology and Biophysics, Medical Faculty in Hradec Králové, Charles University
Co-authors: J. Kremlacek, J. Nekolova, J. Langrova, J. Szanyi, R. Sikl, J. Lukavsky,
D. Moravkova, K. Drtilkova, M. Kuba, Z. Kubova, F. Vit, N. Jiraskova
Tutor: Prof. Naďa Jirásková, M.D., Ph.D.
Introduction
Maculopathy is a dysfunction of macula and is characterized by a progressive loss of central
vision that impairs visual functions and thus unables patients to do normal daily activities. In
developed countries, we most often encounter the age-related macular degeneration (ARMD).
Patients suffering with maculopathy are dependent on the use of optical aids (internal or
external) to be able to read. The external optical aids are used to enlarge the image so that it is
recognizable by the perimacular area of the retina. Unfortunately, they have many limitations.
Therefore, recent emphasis has been placed on the development of intraocular optical aids. In
our study we use the Scharioth intraocular macular lens (SML). SML is a one-piece, add-on
arteficial intraocular lens developed by professor Scharioth. The lens is bifocal, its periphery is
optically neutral or can be individually optically adapted. In the centre of the lens there is an
area of 1.5 mm diameter with addition of plus 10 diopters. The lens is used to improve near
vision, at the same time, the distant vision remains unaffected. Also implantation does not affect
intraocular pressure values or does not narrow the field of view.
Aims
An essential goal of this study is to improve the quality of life of patients with stable
maculopathy. Secondary aims are to verify the effect of transcranial electrical stimulation on
visual rehabilitation and depicting changes in brain plasticity due to both SML implantation and
transcranial electrical stimulation.
Methods
A total of 20 patients will be implanted within 3 years. The follow-up period of one patient is 6
months. To this date, 14 patients has been implanted already, a whole follow-up period is
finished at 10 of them. To join the study patients had to meet strict inclusion and exclusion
criterias. Examinations included assessment of visual acuity, central retinal thickness, contrast
sensitivity, intraocular pressure, visual plasticity in the form of evoked potentials (EP) and
magnetic resonance (MR) and patients‘ subjective satisfaction. The examinations are
performed: preoperatively and then at the day 3, month 1, 2 and 6 after surgery. Only MR
examintation and questionnaires are performed only twice - at the time of indication and at the
last visit. The third day day after implantation a visual rehabilitation and transcranial electrical
stimulation starts and continues for up to another 21 days. Transcranial electrical stimulation is
a low current density electrical current applied to the electrodes placed on the head surface for
several tens of minutes. It serves to modulate brain activity and promote so-called associative
plasticity, it causes subliminal excitability changes in nearby cortical areas, but does not induce
direct reactions or behavioral changes. Side effects, that include pruritus, pricking, redness of
the skin and mild headache, can occur in about 10 % of people, however these symptoms occur
equally frequently in patients with mock stimulation. In our study, transcranial electrical
stimulation is performed in double-blinded design. Visual rehabilitation helps the patient to
learn how to look with a newly implanted lens. The quality of life is assessed using two
questionnaires (MaCDQoL - Macular Disease Dependent Quality of Life and NEI-VFQ -
National Eye Institute Visual Function Questionnaire).
Results
The results of 10 patients are following. In eight patients we found improvement in reading
ability without additional aids or glasses (p = 0.006). The mean distance vision was not
significantly changed, which was also confirmed by the comparison of pre- and post-operative
electrophysiological examinations. Modulation of cortical plasticity by tDCS did not show a
statistically significant effect on reading ability. The questionnaire survey showed that in the
vast majority of patients (9) the positive effects of intervention outweighed the demands of
treatment and stimulation burden.
Conclusion: Intraocular lens implantation and visual rehabilitation have a positive impact on
the capabilities of AMD patients. The results so far have not shown the effect of tDCS
intervention on the measured parameters of visual and cognitive performance. Whether the
effect of current stimulation is at least moderate force will be known after completion of the
second part of the project.
Literature
[1] http://www.medicontur.com/files/For_professionals/A45SML/SML-brochure-doctors-A4-
18-printable.pdf
[2] Grzybowski, A., Wasinska-Borowiec, V., Alio, J. L., a kol.: Intraocular lenses in age-related
macular degeneration. Graefes Arch Clin Exp Ophthalmol (2017) 255: 1687-1696.
[3] Nekolová, J., Rozsíval, P., Šín, M., Jirásková, N.: Scharioth Macula Lens: A new intraocular
implant for low-vision patients with stabilized maculopathy – first experience. Biomed Pap
[4] Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun; 161 (2): 206-209.
Supported by grant AZV NV18-06-00484.
UNCOMMON BACTERIAL SPECIES ISOLATED IN VARIOUS CLINICAL
SPECIMENS IDENTIFIED IN THE NATIONAL REFERENCE LABORATORY
(NRL) FOR ANTIBIOTICS AND IN THE CZECH NATIONAL COLLECTION OF
TYPE CULTURE (CNCTC) IN 2016-2018
Retana Šafránková1,3
1National Institute of Public Health, Prague, 2Regional Hospital Příbram, 3Faculty of Medicine in Hradec Králové, Charles University
Co-authors: L. Mališová1, M. Musílek1, P. Ježek2, H. Žemličková1,3, V. Jakubů1,3
Tutor: Assoc. Prof. Helena Žemličková, M.D., Ph.D.
The Czech National Culture of Type Cultures (CNCTC) was repeatedly asked for identification
of bacterial strains in the last three years. They were not successfully identified in community
(urban or rural) hospitals by standard phenotypic (i.e. microbiological and biochemical) or by
current/modern methods. Strains were isolated in clinical laboratories and they were sent to the
NRL for Antibiotics / the CNCTC as secondary isolates. They were obtained from blood (n=6),
urethral swab (n=1), pus (n=1), ear swab (n=5) and foreskin swab (n=1).
Strains were initially put under extended biochemical tests (API-Biomerieux) and identified by
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS; instrument Bruker Microflex). Samples for API were prepared according to manufacturer
instructions applying to particular API sets. Samples for MALDI-TOF MS were prepared by
both direct and extract methods according to the Bruker´s instructions. Complete identification
of strains (if previously mentioned methods were unsuccessful, went wrong or failed) was
achieved with using 16S rDNA-Sequential Analysis. The sequences were evaluated in the
program BioNumerics 7.6.2 and compared with a publicly accessible database (Nucleotide
BLAST).
Strains were identified as: Lactobacillus sakei, Sphingomonas paucimobilis, Corynebacterium
tuberculostearicum, Moraxella atlantae, Gemella morbillorum, Lactobacillus rhamnosus
(blood), Pasteurella dagmatis (urethral swab), Dialister pneumosintes (pus), Cupriavidus
gilardii, Bacillus siralis, Kerstersia gyiorum, Oligella urethralis, Rhizobium radiobacter (ear
swab), Corynebacterium glucuronolyticum (foreskin swab). Isolates belonged to either rare
taxa or taxa uncommonly associated with given diagnosis. Etiological importance of studied
isolates was not evaluated in relation to their accounting for anticipated or determined
diagnoses.
All strains were deposited in the CNCTC.
The MALDI-TOF MS method is accurate, sensitive, rapid and reproducible method for the
identification and characterization of bacteria, but is not always sufficient, especially for
unusual agents. 16S rDNA-Sequential Analysis is a standard for the classification and
identification of bacterial strain; it can be used to create phylogenetic trees showing the possible
relationship of studied microorganisms.
References
1. Zagorec M. et al.: Lactobacillus sakei: A starter for sausage fermentation, a protective
culture for meat products. Microorganisms, 2017, 5(3), 56.
2. Toh H.S. et al.: Risk factors associated with Sphingomonas paucimobilis infection. J
Microbiol Immunol Infect, 2011, 44(4):289-95.
3. Hinic V. et al.: Corynebacterium tuberculostearicum: a potentially misidentified and
multiresistant Corynebacterium species isolated from clinical specimens. J Clin
Microbiol, 2012, 50(8):2561-7.
4. De Baere T. et al.: Bacteremia due to Moraxella atlantae in a cancer patient. J Clin
Microbiol, 2002, 40(7):2693-5.
5. Zakir R.M. et al.: Mitral bioprosthetic valve endocarditis caused by an unusual
microorganism, Gemella morbillorum, in an intravenous drug user. J Clin Microbiol,
2004, 42(10): 4893-6.
6. Gouriet F. et al.: Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J
Clin Microbiol Infect Dis, 2012, 31(9):2469-80.
7. Xiong J. et al.: Bacteremia due to Pasteurella dagmatis acquired from a dog bite, with a
review of systemic infections and challenges in laboratory identification. Can J Infect Dis
Med Microbiol, 2015, 26(5): 273–6.
8. Rousée J.M. et al.: Dialister pneumosintes associated with human brain abscesses. J Clin
Microbiol, 2002, 40(10): 3871–3.
9. Tena D. et al.: Muscular abscess caused by Cupriavidus gilardii in a renal transplant
recipient. Diagn Microbiol Infect Dis, 2014, 79(1):108-10.
10. Pettersson B. et al.: Bacillus siralis sp. nov., a novel species from silage with a higher
order structural attribute in the 16S rRNA genes. Int J Syst Evol Microbiol, 2000, 50 Pt
6:2181-7
11. Pence M.A. et al.: Two cases of Kerstersia gyiorum isolated from sites of chronic
infection. J Clin Microbiol, 2013, 51(6): 2001–4.
12. Ježek P. et al.: Isolation of Oligella urethralis, a rare species, from a labial cyst of a
gynecological patient. Zprávy CEM (SZÚ, Praha), 2012, 21(1): 19–21.
13. Lai C.C. et al.: Clinical and microbiological characteristics of Rhizobium radiobacter
infections. Clin Infect Dis, 2004, 38(1): 149-53
14. Gherardi G. et al.: Corynebacterium glucuronolyticum causing genitourinary tract
infection: Case report and review of the literature. IDCases, 2015, 2(2): 56–8.
15. Bøvre K. et al.: Moraxella atlantae sp. nov. and its distinction from Moraxella
phenylpyruvica. Int J Syst Bacteriol, 1976, 26, 511-21.
Acknowledgement: Project was supported by SVV 260398.
SINGLE CONTROLLED VISUAL EVOKED POTENTIALS (VEP) DISPLAY
Petr Voda
Co-authors: A. Bezrouk, J. Kremlacek
Tutor: Assoc. Prof. Jan Kremlacek, Ph.D.
Introduction
Reversal pattern visual stimulation in conjunction with evaluating visually evoked potentials
(VEP) is a common examination method used for the diagnosis of disability of visual
sensorial pathways from the peripheral receptors up to the primary visual cortex and is
commonly used to diagnose different disabilities of this pathway, [1]. Optical stimulus for this
examination is to swap the contrasting elements of the displayed structure, usually reversing
black and white blocks of chess (reversal pattern VEP).
Stimulator for these examinations may be the classic mechanical-optical system or the screen
(computer monitor), what brings some problems [2], [3], [4], [5]. Experiments with LED
matrix have been made [6]. Ideal properties of VEP monitors are defined in ISCEV standard
to obtain systems were comparable [7], [8].
The main imperfection common to all referred imaging systems is a long time of reversing of
all the structure in the entire area of the image, the gradual picture arising and reversing of the
entire structure taking certain time [5].
Aims
The aim of the study is to design a device, that displays the image not gradually (by
scanning), but at the same time, having no inertia. To measure properties of such device,
compare to currently used devices (screens) and compare potentials evoked by this device to
potentials evoked using the screen.
Methods
There has been created Single Controlled LED device (SCLED), that contains a very
contrasting array of 144 white light LED elements the size of a 5 mm cubes with flat matte
face placed close side to side with no space between. These elements are custom made to
achieve full opacity between the individual elements. That's a big improvement over the
problems caused by shady bulkheads and dispersion plate [6]. These LEDs are individually
connected to the system of drivers driving each LED individually. The display is controlled
by a microcontroller, what allows to achieve a reversal of the whole structure at once with a
single synchronization pulse coming to all drivers synchronously and allows to create any
(black and white) image consisting of the basic 5mm square elements.
Three types of measurements have been made. 1) Validating electrical and optical properties
of designed SCLED system, 2) measurements on some LCD, TFT and CRT screens to
compare designed SCLED display, 3) testing of the SCLED device on persons in
experimental conditions of real physiological laboratory and comparison of the device with
CRT monitor used now for analysis.
Results
1) The measured rise time of designed SCLED is 20 us, what is 100 times faster than
commonly used LCD display. Easing all LEDs in the entire area of the display is synchronous
and the time of lightning of all LEDs is the same.
Additionally, the brightness, its settling and its
stability during the time was measured and
compared.
2) Measurements of conventional LCD TFT and
CRT monitors with two matching calibrated probes
show that changes brightness of individual parts of
the image and its stability in time at various types
of display is much worse compared to designed
LED display.
3) The results of measurements of persons were
designed into graphs marked with the letters of
persons. Red line in graph represents using CRT
screen, blue line is designed SCLED stimulator.
First column is obtained using 5mm square
checkboard, second column represents 10mm
square checkboard.
Discussion
Measurements implies that the whole required structure of SCLED device lights up during
20us what is 100 times faster than commonly used LCD display. The stabilization of
brightness (however in 10% fluctuation only) takes 5ms and brightness of the display is stable
all the time. That is also much better than common LCD display, what is 4 times slower. The
voltage of the probe when LED is off, is not measurable, thus device has a very high contrast.
Measurements by two probes taken on CRT monitor show very quick easing of brightness,
but also just a very short time of illumination. One can see very clearly the low contrast of the
monitor and the time difference between easing the element at the top and bottom of the
image (up to 10 ms). Flickering can be seen clearly on CRT tube recording. With
conventional LCD (TFT) is the full brightness rising time 20 ms, descending time 2ms. Rising
time of the structure using mechanical-optical VEP system is 2 ms [5].
Measured electrical and optical characteristics of the designed and completed apparatus are
significantly better than the existing types of stimulators. The most important parameter (time
of easing and the speed of reversal of the whole structure) is several orders of magnitude
better. Also the stability of the brightness and speed of the exchange of individual images is
significantly higher than for the other types. Differences in the measured responses for few
persons are not significant, but it can be stated, that the realized SCLED stimulator gives a
slightly better results. Due to the small size of the stimulator the only a small part of the
Visual field is stimulated, so latency of displaying distant parts of the image not apply much.
The results of our measurements correspond with the findings in [4], [2].
Conclusion
There was created a new prototype of Single controlled LED (SCLED) pattern shift VEP
Stimulator. Its electrical and optical characteristics are significantly better than the existing
types of stimulators. Pilot testing on the small group of tesing people shows that this SCLED
stimulator is suitable for examination of the VEPs and gives at least similar, maybe slightly
better, results than conventional CRT monitors.
Therefore, it has a sense to think about the construction of larger display assembled from
several here designed SCLED stimulators used as serialized modules controlled by one
common microcontroller. It can be assumed, that such a very synchronous stimulator, featured
with zero latency of individual parts of the image can provide better results than conventional
monitors used to stimulation, whether the CRT or now used LCD or OLED displays.
Acknowledgement
This work was supported by the programme PROGRES Q40-09
Literature
[1] Kuba, M. (2008). Motion-onset visual evoked potentials and their diagnostic applications:
Teze disertace k ziskani vedeckeho titulu "doktor ved" ve skupine ved: "Molekularne-
biologicke a lekarske vedy". Brno: MSD.
[2] Zhang, G., Li, A., Miao, C., He, X., Zhang, M., & Zhang, Y. (2018). A consumer-grade
LCD monitor for precise visual stimulation. Behavior Research Methods.
doi:10.3758/s13428-018-1018-7
[3] Nagy, B. V., Gemesi, S., Heller, D., Magyar, A., Farkas, Á, Ábraham, G., & Varsanyi, B.
(2011). Comparison of pattern VEP results acquired using CRT and TFT stimulators in
the clinical practice. Documenta Ophthalmologica,122(3), 157-162. doi:10.1007/s10633-
011-9270-5
[4] Cooper, E.A., Jisng, H., Vildavski, V., Farrell, J.E., &Nortica, A.M. (2013) Assessment
of OLED displays for vision research. Journal of Vision,13(12):16, 1-12.
doi:10.1167/13.12.16
[5] Kubova, Z., Kuba, M., Spekreijse, H., & Blakemore, C. (1995). Contrast dependence of
motion-onset and pattern-reversal evoked potentials. Vision Research, 35(2), 197-205.
doi:10.1016/0042-6989(94)00138-c
[6] Link, B., Rühl, S., Peters, A., Jünemann, A., & Horn, F. K. (2006). Pattern Reversal ERG
and VEP – Comparison of Stimulation by LED, Monitor and a Maxwellian-view System.
Documenta Ophthalmologica,112(1), 1-11. doi:10.1007/s10633-005-5865-z
[7] Odom, J. V., Bach, M., Brigell, M., Holder, G. E., Mcculloch, D. L., Mizota, A., &
Tormene, A. P. (2016). ISCEV standard for clinical visual evoked potentials: (2016
update). Documenta Ophthalmologica,133(1), 1-9. doi:10.1007/s10633-016-9553-y
[8] Odom, J. V., Bach, M., Brigell, M., Holder, G. E., Mcculloch, D. L., Tormene, A. P., &
V. (2009). ISCEV standard for clinical visual evoked potentials (2009 update).
Documenta Ophthalmologica,120(1), 111-119. doi:10.1007/s10633-009-9195-4